Nature Communications (Jul 2020)

Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model

  • Kevin A. Guttenplan,
  • Maya K. Weigel,
  • Drew I. Adler,
  • Julien Couthouis,
  • Shane A. Liddelow,
  • Aaron D. Gitler,
  • Ben A. Barres

DOI
https://doi.org/10.1038/s41467-020-17514-9
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 9

Abstract

Read online

Astrocyte activation may contribute to neurodegenerative disease. Here the authors show that the combined knockout of three factors known to promote astrogliosis, IL-1α, TNFα and C1qa, leads to improved survival in the SOD1 G93A mouse model of ALS.